The authors showed that the detection of CTCs with the expression of PD-L1 at the completion of the final treatment in HNSCC patients correlated with a higher risk of progression and mortality compared with the negative analogs of PD-L1. The gene discussed is CD274; the disease is head and neck squamous cell carcinoma.